Studying the structure and regulation of soluble guanylyl cyclase.
暂无分享,去创建一个
[1] G. Schultz,et al. Stimulation of soluble guanylate cyclase by superoxide dismutase is mediated by NO. , 1998, The Biochemical journal.
[2] C. Harteneck,et al. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. , 1998, The Biochemical journal.
[3] M. Marletta,et al. Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. , 1998, Chemistry & biology.
[4] Y. Zhao,et al. Identification of histidine 105 in the beta1 subunit of soluble guanylate cyclase as the heme proximal ligand. , 1998, Biochemistry.
[5] Yunde Zhao,et al. Localization of the heme binding region in soluble guanylate cyclase. , 1997, Biochemistry.
[6] S R Sprang,et al. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. , 1997 .
[7] D. Magde,et al. Dissociation of nitric oxide from soluble guanylate cyclase. , 1997, Biochemical and biophysical research communications.
[8] R. Danziger,et al. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. , 1997, The Journal of clinical investigation.
[9] T. Kitagawa,et al. Purification of bovine soluble guanylate cyclase and ADP-ribosylation on its small subunit by bacterial toxins. , 1997, Journal of biochemistry.
[10] R. Fischmeister,et al. A comparative study of the effects of three guanylyl cyclase inhibitors on the L‐type Ca2+ and muscarinic K+ currents in frog cardiac myocytes , 1997, British journal of pharmacology.
[11] D. Magde,et al. Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase. , 1997, Biochemistry.
[12] S. Kuo,et al. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. , 1997, European journal of pharmacology.
[13] G. Schultz,et al. Functions of conserved cysteines of soluble guanylyl cyclase. , 1997, Biochemistry.
[14] R. Busse,et al. Effect of YC‐1, an NO‐independent, superoxide‐sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators , 1997, British journal of pharmacology.
[15] G. Schultz,et al. Sensitizing soluble guanylyl cyclase to become a highly CO‐sensitive enzyme. , 1996, The EMBO journal.
[16] G. Schultz,et al. A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits. , 1996, European journal of biochemistry.
[17] C. Dessauer,et al. Purification and Characterization of a Soluble Form of Mammalian Adenylyl Cyclase* , 1996, The Journal of Biological Chemistry.
[18] G. Schultz,et al. Positive effects of pollution? , 1996, Nature.
[19] B. Mayer,et al. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. , 1996, Molecular pharmacology.
[20] B. Mayer,et al. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. , 1996, The Journal of pharmacology and experimental therapeutics.
[21] M. Marletta,et al. Heme stoichiometry of heterodimeric soluble guanylate cyclase. , 1995, Biochemistry.
[22] G. Schultz,et al. Functional Domains of Soluble Guanylyl Cyclase (*) , 1995, The Journal of Biological Chemistry.
[23] S. Kuo,et al. YC‐1 inhibited human platelet aggregation through NO‐independent activation of soluble guanylate cyclase , 1995, British journal of pharmacology.
[24] S. Moncada,et al. Molecular mechanisms and therapeutic strategies related to nitric oxide , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] C. Harteneck,et al. A Variant of the α2 Subunit of Soluble Guanylyl Cyclase Contains an Insert Homologous to a Region within Adenylyl Cyclases and Functions as a Dominant Negative Protein (*) , 1995, The Journal of Biological Chemistry.
[26] A. Gilman,et al. Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin. , 1995, Science.
[27] E. Wilson,et al. Identification of sequences mediating guanylyl cyclase dimerization. , 1995, Biochemistry.
[28] U. Walter,et al. NO at work , 1994, Cell.
[29] M. Marletta,et al. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. , 1994, Biochemistry.
[30] D. Garbers,et al. Dominant negative mutants of nitric oxide-sensitive guanylyl cyclase. , 1994, The Journal of biological chemistry.
[31] T. Lincoln,et al. Intracellular cyclic GMP receptor proteins , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] G. Schultz,et al. Molecular cloning and expression of a new α‐subunit of soluble guanylyl cyclase Interchangeability of the α‐subunits of the enzyme , 1991 .
[33] F. Murad,et al. Expression of soluble guanylate cyclase activity requires both enzyme subunits. , 1991, Biochemical and biophysical research communications.
[34] D. Garbers,et al. A new form of guanylyl cyclase is preferentially expressed in rat kidney. , 1990, Biochemistry.
[35] G. Schultz,et al. Expression of soluble guanylyl cyclase , 1990, FEBS letters.
[36] B. Brüne,et al. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. , 1990, European journal of biochemistry.
[37] G. Schultz,et al. Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. , 1990, European journal of biochemistry.
[38] J. Garthwaite,et al. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.
[39] F. Murad,et al. Cyclic GMP synthesis and function. , 1987, Pharmacological reviews.
[40] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[41] F. Murad,et al. Soluble guanylate cyclase from rat lung exists as a heterodimer. , 1986, The Journal of biological chemistry.
[42] G. Schultz,et al. Soluble guanylate cyclase purified from bovine lung contains heme and copper , 1981, FEBS letters.
[43] D. Garbers. Purification of soluble guanylate cyclase from rat lung. , 1979, The Journal of biological chemistry.